vs

Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and NATURAL RESOURCE PARTNERS LP (NRP). Click either name above to swap in a different company.

BillionToOne, Inc. is the larger business by last-quarter revenue ($83.5M vs $51.3M, roughly 1.6× NATURAL RESOURCE PARTNERS LP). NATURAL RESOURCE PARTNERS LP runs the higher net margin — 78.5% vs 6.8%, a 71.7% gap on every dollar of revenue. On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs -21.8%).

BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.

Natural Resource Partners LP is a U.S.-headquartered master limited partnership that owns, manages and leases mineral reserve interests. Its asset portfolio covers coal, aggregates, industrial minerals and oil & gas, with operations primarily across North America, deriving most revenue from royalties paid by third-party resource extraction operators.

BLLN vs NRP — Head-to-Head

Bigger by revenue
BLLN
BLLN
1.6× larger
BLLN
$83.5M
$51.3M
NRP
Growing faster (revenue YoY)
BLLN
BLLN
+139.2% gap
BLLN
117.4%
-21.8%
NRP
Higher net margin
NRP
NRP
71.7% more per $
NRP
78.5%
6.8%
BLLN

Income Statement — Q3 FY2025 vs Q1 FY2025

Metric
BLLN
BLLN
NRP
NRP
Revenue
$83.5M
$51.3M
Net Profit
$5.7M
$40.3M
Gross Margin
69.9%
Operating Margin
11.5%
83.7%
Net Margin
6.8%
78.5%
Revenue YoY
117.4%
-21.8%
Net Profit YoY
138.3%
-28.4%
EPS (diluted)
$0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BLLN
BLLN
NRP
NRP
Q3 25
$83.5M
Q1 25
$51.3M
Q4 24
$45.1M
$61.8M
Q3 24
$38.4M
$50.4M
Q2 24
$54.6M
Q1 24
$65.6M
Q4 23
$72.9M
Q3 23
$68.5M
Net Profit
BLLN
BLLN
NRP
NRP
Q3 25
$5.7M
Q1 25
$40.3M
Q4 24
$-11.5M
$42.8M
Q3 24
$-14.9M
$38.6M
Q2 24
$46.1M
Q1 24
$56.2M
Q4 23
$65.0M
Q3 23
$63.8M
Gross Margin
BLLN
BLLN
NRP
NRP
Q3 25
69.9%
Q1 25
Q4 24
57.1%
Q3 24
52.6%
Q2 24
Q1 24
Q4 23
Q3 23
Operating Margin
BLLN
BLLN
NRP
NRP
Q3 25
11.5%
Q1 25
83.7%
Q4 24
17.0%
74.9%
Q3 24
-32.9%
84.9%
Q2 24
92.3%
Q1 24
91.0%
Q4 23
94.5%
Q3 23
98.8%
Net Margin
BLLN
BLLN
NRP
NRP
Q3 25
6.8%
Q1 25
78.5%
Q4 24
-25.5%
69.2%
Q3 24
-38.8%
76.6%
Q2 24
84.4%
Q1 24
85.7%
Q4 23
89.1%
Q3 23
93.2%
EPS (diluted)
BLLN
BLLN
NRP
NRP
Q3 25
$0.10
Q1 25
Q4 24
$-1.13
Q3 24
$-1.47
Q2 24
Q1 24
Q4 23
Q3 23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BLLN
BLLN
NRP
NRP
Cash + ST InvestmentsLiquidity on hand
$195.2M
$30.9M
Total DebtLower is stronger
$55.0M
$138.8M
Stockholders' EquityBook value
$-239.5M
Total Assets
$327.5M
$772.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BLLN
BLLN
NRP
NRP
Q3 25
$195.2M
Q1 25
$30.9M
Q4 24
$191.5M
$30.4M
Q3 24
$30.9M
Q2 24
$32.3M
Q1 24
$11.0M
Q4 23
$12.0M
Q3 23
$18.4M
Total Debt
BLLN
BLLN
NRP
NRP
Q3 25
$55.0M
Q1 25
$138.8M
Q4 24
$51.5M
$142.1M
Q3 24
$197.4M
Q2 24
$210.3M
Q1 24
$188.8M
Q4 23
$155.1M
Q3 23
$207.5M
Stockholders' Equity
BLLN
BLLN
NRP
NRP
Q3 25
$-239.5M
Q1 25
Q4 24
$-251.7M
Q3 24
$-242.9M
Q2 24
Q1 24
Q4 23
Q3 23
Total Assets
BLLN
BLLN
NRP
NRP
Q3 25
$327.5M
Q1 25
$772.5M
Q4 24
$302.1M
$772.9M
Q3 24
$772.9M
Q2 24
$789.6M
Q1 24
$772.9M
Q4 23
$797.9M
Q3 23
$815.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BLLN
BLLN
NRP
NRP
Operating Cash FlowLast quarter
$13.8M
$34.4M
Free Cash FlowOCF − Capex
$6.5M
FCF MarginFCF / Revenue
7.7%
Capex IntensityCapex / Revenue
8.8%
Cash ConversionOCF / Net Profit
2.42×
0.86×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BLLN
BLLN
NRP
NRP
Q3 25
$13.8M
Q1 25
$34.4M
Q4 24
$66.2M
Q3 24
$54.1M
Q2 24
$56.6M
Q1 24
$71.5M
Q4 23
$77.8M
Q3 23
$78.9M
Free Cash Flow
BLLN
BLLN
NRP
NRP
Q3 25
$6.5M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
Q3 23
FCF Margin
BLLN
BLLN
NRP
NRP
Q3 25
7.7%
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
Q3 23
Capex Intensity
BLLN
BLLN
NRP
NRP
Q3 25
8.8%
Q1 25
Q4 24
0.0%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.0%
Q4 23
0.0%
Q3 23
0.0%
Cash Conversion
BLLN
BLLN
NRP
NRP
Q3 25
2.42×
Q1 25
0.86×
Q4 24
1.55×
Q3 24
1.40×
Q2 24
1.23×
Q1 24
1.27×
Q4 23
1.20×
Q3 23
1.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BLLN
BLLN

Prenatal$74.1M89%
Oncology$8.7M10%

NRP
NRP

Coal Royalty Revenues$35.5M69%
Soda Ash Segment$4.6M9%
Transportation And Processing Services$4.4M9%
Production Lease Minimum Revenues$2.7M5%
Oil And Gas Royalty Revenues$2.4M5%
Other$1.6M3%

Related Comparisons